ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patien... ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. 더 보기
Cash on Hand Utilized to Repay $30 Million of Senior Secured Term Loan Facility to Ares Capital Lowers ADMA’s Total Debt to $75 Million, a 29% Reduction Further Supports Earnings Growth Outlook...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.8144 | 4.60227401162 | 17.6956 | 18.77 | 16.95 | 1777252 | 17.54481022 | CS |
4 | -0.98 | -5.02821959979 | 19.49 | 19.92 | 16.95 | 2248428 | 18.22533753 | CS |
12 | 1.38 | 8.05604203152 | 17.13 | 23.64 | 15.33 | 3225028 | 18.76920114 | CS |
26 | 7.06 | 61.6593886463 | 11.45 | 23.64 | 10.33 | 4130333 | 17.60725717 | CS |
52 | 13.97 | 307.709251101 | 4.54 | 23.64 | 4.37 | 3487877 | 13.45194501 | CS |
156 | 17.11 | 1222.14285714 | 1.4 | 23.64 | 1.26 | 2808437 | 7.31096772 | CS |
260 | 14.63 | 377.06185567 | 3.88 | 23.64 | 1.01 | 3201951 | 4.90235612 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관